Bedaquiline: A new drug approved for treatment of multidrug-resistant tuberculosis

被引：53
作者：
Deoghare, Shashank [1 ]
机构：
[1] Govt Med Coll, Dept Pharmacol, Surat, Gujarat, India
来源：
INDIAN JOURNAL OF PHARMACOLOGY | 2013年 / 45卷 / 05期
关键词：
MYCOBACTERIAL ATP SYNTHASE;
D O I：
10.4103/0253-7613.117765
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：536 / U120
页数：2
相关论文
共 7 条
[1]   Selectivity of TMC207 towards Mycobacterial ATP Synthase Compared with That towards the Eukaryotic Homologue [J].
Haagsma, Anna C. ;
Abdillahi-Ibrahim, Rooda ;
Wagner, Marijke J. ;
Krab, Klaas ;
Vergauwen, Karen ;
Guillemont, Jerome ;
Andries, Koen ;
Lill, Holger ;
Koul, Anil ;
Bald, Dirk .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (03) :1290-1292
[2]   In vitro antimycobacterial spectrum of a diarylquinoline ATP synthase inhibitor [J].
Huitric, Emma ;
Verhasselt, Peter ;
Andries, Koen ;
Hoffner, Sven E. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (11) :4202-4204
[3]   Diarylquinolines target subunit c of mycobacterial ATP synthase [J].
Koul, Anil ;
Dendouga, Najoua ;
Vergauwen, Karen ;
Molenberghs, Brenda ;
Vranckx, Luc ;
Willebrords, Rudy ;
Ristic, Zorica ;
Lill, Holger ;
Dorange, Ismet ;
Guillemont, Jerome ;
Bald, Dirk ;
Andries, Koen .
NATURE CHEMICAL BIOLOGY, 2007, 3 (06) :323-324
[4]  
National Research Council, 2000, END NEGL EL TUB US
[5]  
U.S. Food and Drug Administration, SIRTURO PRESCR INF
[6]  
US Food and Drug Administration, NDA 204 384 DEP DIV
[7]  
WHO, Global tuberculosis report 2012
1